Click to discover upcoming conferences and workshops
Read about projects and research interests of our collaborators…
Watch recorded presentations and talks from our network events …
Focus workshops addressing the challenges of stratified medicine …
Courses and seminars on genetics, genomics and stratified medicine…
Funding opportunities for research into stratified medicine
27 Sep 2017
MRC/AstraZeneca Centre for Lead Discovery
27 Sep 2017
MRC/UCB Antibody Discovery Initiative
11 Oct 2017
Digital Health Technology Catalyst 2017 Round 1
11 Oct 2017
New and novel healthcare solutions: apply for innovation funding
13 Oct 2017
NICE AdviSeME Prize
25 Oct 2017
Precision medicine: impacting through innovative technology
27 Oct 2017
SBRI funding competition: Exploiting data to improve cancer care
07 Nov 2017
MRC Confidence in Concept scheme 2017
15 Jan 2018
JLABS @ NYC QuickFire Challenge
Articles from the field of stratified medicine and pharmacogenetics... European…
The high profile committee guiding the UK PGx Network…
Upcoming Events & Funding Deadlines
The network is made up of experts from academia, healthcare sector, industry, regulatory bodies and patient groups
and aims to develop collaborations between these different sectors to advance the adoption of stratified medicine into the clinic.
If you need to find a research partner, simply click to download the collaboration form, provide information on your current project(s)
and we will advertise your request to help put you in touch with the relevant individual or institution.
What is Pharmacogenetics?
What is Stratified Medicine?
Stratified medicine (also described as personalised, precision, or P4 Predictive, Preventive, Personalized and Participatory medicine) uses technical advances in genetic sequencing techniques, and bespoke diagnostic tests, to prescribe the drug that is most likely to have a positive therapeutic effect, at the optimum dose and in the right combination with other medication, to patients at the start of their treatment. Thus patients have their treatment based on their genetic profile, molecular basis of their disease, risk of disease, or response to a particular drug therapy, rather than the signs or symptoms of their disease.
Traditionally patients have been prescribed their medication based on the signs and symptoms of their disease. If a treatment is not successful patients have to be prescribed an alternative medication.
Academic and clinical research has revealed that most diseases have multiple subtypes that require different treatment approaches. Pharmacogenetic data and bespoke diagnostic tests enable clinicians to identify the subcategory of disease and offer patients the most effective treatments from the outset of their treatment.